特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ヘルスケア産業のインドにおける展望:2020年

Outlook of India's Healthcare Industry, 2020

発行 Frost & Sullivan 商品コード 939663
出版日 ページ情報 英文 42 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。
ヘルスケア産業のインドにおける展望:2020年 Outlook of India's Healthcare Industry, 2020
出版日: 2020年05月11日 ページ情報: 英文 42 Pages
概要

インドのバイオシミラー市場は2020年までに9億米ドルを超えると予測されています。インドおよび世界的にも、高齢化の進行による慢性疾患の有病率が増加していることに加えて、「メイド・イン・インディア」での製造に向けた政府の取り組みと世界な高品質で低コスト治療の必要性は、製薬会社からのヘルスケア産業への投資につながり、それによってバイオシミラー市場の発展が促進されています。テレヘルス市場は、2020年に4億5010万米ドルとなり、2026年まで21%のCAGRで拡大すると予測されています。National Health Portal、オンライン登録システム、e-Hospital,などの政府イニシアチブは、大衆の間にe-ヘルスケアモデルの嗜好・導入を高めると予測されています。

当レポートでは、インドのヘルスケア産業について調査し、業界の動向、予測、および成長機会などについて分析しています。

エグゼクティブサマリー

  • 2020年の主な予測

調査範囲とセグメンテーション

  • 調査範囲

インドのヘルスケア業界動向

  • インドのヘルスケア業界規模:スナップショット
  • セグメント別のインドのヘルスケア業界規模

主要な予測:インド産業

  • 予測1:インドのバイオシミラー業界は2020年までに9億米ドルを超える見込み
  • 予測2:Ayushman Bharatは、医療機関からの医療機器の需要を後押しすることが期待される
  • 予測3:遠隔医療は2020年に4億5000万米ドルとなり、2026年まで21%のCAGRで成長する可能性が高い
  • 予測4:インドのヘルス&ウェルネスツーリズムセクターは、医療観光業界で最も成長しているセクターになる

成長機会および推奨行動

  • 5つの主要な成長機会
  • 成長機会1:API契約製造
  • 成長機会2:ポイントオブケア (POC) テスト
  • 成長機会3:オンライン薬局
  • 成長機会4:デジタル病理学
  • 成長機会5:医療画像サービス
  • 成功と成長のための戦略的必須事項

主な結論

  • 主な結論
  • 免責事項

付録

Frost & Sullivanについて

目次
Product Code: PAE2-48

Indian Healthcare Industry is Expected to Grow at 16.9% in 2020 to Reach $272.79 Billion in 2020

The study covers the healthcare market which develops and provides products, solutions, and/or services across the care spectrum for diagnosis, treatment, and prevention.

The biosimilars market in India is expected to cross $0.9 billion by 2020. The growing prevalence of chronic diseases with an increasing aged population in India and globally, coupled with government initiatives for manufacturing under 'Make in India' and the global need for lower cost therapies at high quality has led to health investments from the pharmaceutical players, thereby fostering development of the biosimilars market.

With about 14 million patients treated till December 2020, Ayushman Bharat is expected to boost demand for medical devices from empanelled hospitals. Given the perception of hospitals and ensuing impact on medical device and consumables manufacturers, it may be prudent for medical device manufacturers to prioritize alignment with secondary care hospitals, especially in Tier II/III cities and below. Increase in demand for cardiac stents, orthopaedic implants due to increased uptake of secondary specialties from hospitals is also expected.

The $450.1-Mn market for Telehealth in 2020 is likely to grow at a CAGR of 21% till 2026. Government initiatives like the National Health Portal, online registration system, e-Hospital, etc. are expected to increase preference and adoption of e-Healthcare models among masses. This is expected especially in the areas of stress management and behavioural health extending up to the larger spectrum of cardiology, diabetes, and oncology. Startups like Wellthy Therapeutics have gained traction by focusing on the cardiac and diabetes segment.

India's health and wellness tourism sector will be the highest growing within medical tourism. India offers the unique proposition of AYUSH services that are a major attraction for medical tourists, especially from Europe and other developed countries.

In light of the overloaded and strained clinical pipelines and decreasing returns on investment on Research and Development (R&D), CMOs will need to support pharma companies in introducing innovation by offering improved manufacturing efficiencies and data analytics solutions.

As molecular diagnostics is guiding the treatment pathway for cancer, digital pathology will move beyond conventional histopathology to integrate genomic information. Despite the recent advancements in digital pathology, better quality control guidelines are needed right from sample preparation to whole slide imaging and image analysis.

Also, independent quality assessment guidelines for different software are needed for automated quantification and for making a uniform assessment of image analysis.

Innovation in radiology business models can fuel the growth of diagnostic imaging in India. Public-private partnerships in radiology services and payments made for the services utilised, has seen some success. Most of the developed countries are moving from departmental PACS to VNA / Enterprise PACS. Without the large-scale adoption of this basic infrastructure, it would be difficult to envision implementation of new-age solutions such as AI, enterprise imaging, and precision medicine.

Table of Contents

Executive Summary

  • Top Predictions for 2020

Research Scope and Segmentation

  • Research Scope

India Healthcare Industry Trends

  • India Healthcare Industry Size-A Snapshot
  • Indian Healthcare Industry Size by Segment, 2020E

Key Predictions-Indian Industry

  • Prediction 1-The Biosimilars Industry in India is Expected to Cross $0.90 Billion by 2020
  • Prediction 2-Ayushman Bharat is Expected to Boost Demand for Medical Devices from Empanelled Hospitals
  • Prediction 3-$450.10 Million of Telehealth in 2020 is Likely to Grow at a CAGR of 21% Till 2026
  • Prediction 4-India's Health and Wellness Tourism Sector will be the Highest Growing Sector within Medical Tourism

Growth Opportunities and Companies to Action

  • 5 Major Growth Opportunities
  • Growth Opportunity 1-API Contract Manufacturing
  • Growth Opportunity 2-Point-of-Care Testing
  • Growth Opportunity 3-Online Pharmacies
  • Growth Opportunity 4-Digital Pathology
  • Growth Opportunity 5-Medical Imaging as a Service
  • Strategic Imperatives for Success and Growth

Key Conclusions

  • Key Conclusions
  • Legal Disclaimer

Appendix

  • Industry Segmentation
  • Industry Definition-Hospital
  • Industry Definition-Pharmaceuticals and Biotechnology
  • Industry Definition-Medical Technologies
  • Industry Definition-Medical Technologies (continued)
  • Industry Definition-HIT
  • List of Exhibits

The Frost & Sullivan Story

  • The Frost & Sullivan Story
  • Value Proposition-Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360º Research Perspective
  • Implementation Excellence
  • Our Blue Ocean Strategy